Navigation Links
Omega Laboratories Applauds the Adoption of Enzyme Immunoassay (EIA) by Major Hair Testing Laboratories
Date:6/13/2012

MOGADORE, Ohio, June 13, 2012 /PRNewswire/ -- Omega Laboratories, Inc. recognizes and applauds yesterday's announcement that the remaining laboratory of those accredited by the College of American Pathologists (CAP) for forensic hair drug testing has decided to utilize Enzyme Immunoassay technology. This announcement comes after a decade of disagreement and confusion regarding differing methodologies and proprietary techniques. This change could signal that the hair testing industry has finally come to a consensus on the superiority of Enzyme Immunoassay technology as a screening method for drugs of abuse.

This announcement represents a unity of methodology within the hair testing industry, as all three major workplace hair testing laboratories now use EIA as their screening method of choice. Omega anticipates that this harmonization on screening methodologies will aid in the acceptance of hair testing by the Substance Abuse and Mental Health Services Administration (SAMHSA) and their Drug Testing Advisory Board (DTAB).

Omega Laboratories has chosen to use Enzyme Immunoassay (EIA) technology since its inception in 2000, citing superior accuracy, reliability, and low impact upon the environment. Omega's use of EIA for 12 years has contributed to its position as a leader in the hair testing industry, allowing Omega to be an active and successful participant in worldwide proficiency testing programs. In addition, it has aided Omega in securing prestigious international accreditations and Food and Drug Administration (FDA) clearances for the company's screening assays.

Enzyme Immunoassay (EIA) is a quick and cost effective biochemistry assay used to identify the presence of substances within specimens. When used for drugs of abuse screening, this technology allows laboratories to efficiently and accurately detect drugs of abuse in hair specimens, which can then be confirmed through GC/MS and LC/MS technology. Since the 1992 publication of a World Health Organization study, which highlights the benefits of EIA technology, EIA has become the prevailing method of choice worldwide.

A common predecessor of EIA is Radioimmunoassay (RIA), which uses radioactive signal to detect substances within a sample. Some members of the hair testing for drugs of abuse industry have continued to market the use of RIA technology, despite widespread knowledge that this practice creates radioactive waste, which raises environmental concerns.

"It is exciting to hear that another laboratory has joined Omega in using Enzyme Immunoassay technology," said Dr. John Vitullo, CEO of Omega Laboratories.  "We have used this technology at Omega for over 12 years with great success and we know that the adoption of EIA by our competitors will not only be better for the environment, but will also help to establish equivalence and convergence in hair testing results across different laboratories."

In addition to numerous international accreditations, Omega Laboratories has utilized EIA to receive FDA screening assay clearances for its Cocaine, Methamphetamine, PCP, and Opiates panels, and is the only hair testing laboratory to have documented clearance for Codeine, Oxycodone and Hydrocodone testing.

About Omega Laboratories, Inc. - Omega Laboratories, Inc. is a state-of-the-art facility providing laboratory-based hair and oral fluid testing for drugs of abuse to over 5,000 clients worldwide.  Omega currently holds ISO/IEC 17025 and CAP alternative specimen testing accreditations, as well as screening clearances from the FDA. Omega's reputation for performing accurate, timely and cost effective testing, coupled with an unmatched reputation for client service, has positioned Omega as the leader in the alternative specimen drug testing industry.  

http://www.omegalabs.net/

CONTACT: Mark Freemal, +1-800-665-5569


'/>"/>
SOURCE Omega Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PeaceHealth Laboratories New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
2. Everett Laboratories, Inc. Files Patent Infringement Lawsuit Against Competitor Trigen Laboratories, Inc.
3. New Data Support Role of Prometheus Laboratories Novel Assay in Optimizing IBD Treatment Management
4. Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation
5. Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
6. Millennium Laboratories Sponsors Educational Programs in Support of Safe Prescribing Practices at Regional Pain Society Conferences
7. Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages
8. CHPA Applauds Arizonas Adoption Of HB 2263
9. Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
10. CHPA Applauds Alabamas Adoption Of HB 363
11. CHPA Applauds Alabama Senates Passage of Anti-Meth Bill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2019)... SPRINGS, Fla. (PRWEB) , ... November 15, 2019 , ... ... continued charitable partnership. Hope For The Warriors was founded by the military ... effects war can have on service members and their families. For the past 13 ...
(Date:11/14/2019)... ... November 14, 2019 , ... Kaden, the digital behavioral health company (formerly ... New Hampshire. The company is exploring a collaborative effort with Catholic Medical Center ... disorder in the state. , Kaden is pleased to be a sponsor of ...
(Date:11/14/2019)... (PRWEB) , ... November 14, 2019 , ... ... for clinical trials, announced today that it has reached a milestone in the ... in more than 200 regulatory submissions from biopharmaceutical clients for therapies and indications ...
Breaking Medicine Technology:
(Date:11/14/2019)... ... November 14, 2019 , ... PMB-developed medical facilities have ... program. The three projects include an adaptive reuse movie theater project in Goodyear, ... Calif. that provides medical care to an underserved community; and an urban high-rise ...
(Date:11/12/2019)... ... November 12, 2019 , ... Each year, RESOLVE (The ... impacted those diagnosed with infertility. This year, Academy of Adoption and Assisted Reproduction ... at the Night of Hope Gala in New York City on November 11, ...
(Date:11/12/2019)... ... November 12, 2019 , ... ... today announced that Tidewater Physicians Multispecialty Group (TPMG), a network of ... Outcomes® patient engagement platform to deliver enhanced patient experience and overall ...
(Date:11/12/2019)... ... November 12, 2019 , ... Certemy, a ... announced the release of new features for custom branding. The new features allow ... to match their physical brand attributes. Customizable attributes include customer logo, an optional ...
(Date:11/11/2019)... (PRWEB) , ... November 11, 2019 , ... ... business support services to dental groups in the United States, today announced the ... community of Lodi, CA. , Patients will enjoy convenient hours, comfortable offices and ...
Breaking Medicine News(10 mins):